Variation of platelet production and discard rates in 17 blood centers representing 10 European countries from 2000 to 2002

Transfusion

Volumn 46, Issue 6, 2006, Pages 991-995

  Veihola, Marketta ^a   Aroviita, Pekka ^b   Linna, Miika ^b   Sintonen, Harri ^b   Kekomäki, Riitta ^b  

^a FINNISH RED CROSS BLOOD SERVICE   (Finland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTIC METHOD; ARTICLE; BLOOD BANK; BLOOD COMPONENT; BLOOD DONOR; CONTROLLED STUDY; EUROPE; HOSPITAL; HUMAN; HUMAN CELL; INFORMATION PROCESSING; RETROSPECTIVE STUDY; THROMBOCYTE VOLUME; THROMBOCYTOPHERESIS; THROMBOCYTOPOIESIS;

BLOOD BANKS; BLOOD PLATELETS; EQUIPMENT AND SUPPLIES; EUROPE; HUMANS; PLATELETPHERESIS; QUALITY CONTROL; RETROSPECTIVE STUDIES;

EID: 33744480272     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2006.00832.x     Document Type: Article

References (30)

1. Guide to the preparation, use and quality assurance of blood components. Recommendation R(95)15, 11th ed. Strasbourg : Council of Europe Publishing 2005.
2. Directive 2002/98/EC of the European Parliament and of the Council of 27 January 2003 setting standards of quality and safety for the collection, testing, processing, storage and distribution of human blood and blood components and amending Directive 2001/83/EC [monograph on the Internet]. Official Journal L 033, 08/02/2003 P.0030-0040. Brussels : European Commission 2004. Available from: http://europa.eu.int/comm/health/horiz_legal.htm#32
3. Faber JC. The European Blood Directive: a new era of blood regulation has begun. Transfus Med 2004 14 : 257 73.
4. Reynolds E, Wickenden C, Oliver A. The impact of improved safety on maintaining a sufficient blood supply. Transfus Clin Biol 2001 8 : 235 9.
5. Goodnough LT, Shander A, Brecher ME. Transfusion medicine: looking to the future. Lancet 2003 361 : 161 9.
6. Wilson K, Hebert PC. The challenge of an increasingly expensive blood system. CMAJ 2003 168 : 1149 50.
7. AuBuchon JP, Cooper LK, Leach MF, et al. Experience with universal bacterial culturing to detect contamination of apheresis platelet units in a hospital transfusion service. Transfusion 2002 42 : 855 61.
8. Hillyer CD, Josephson CD, Blajchman MA, et al. Bacterial contamination of blood components: risks, strategies, and regulation: joint ASH and AABB educational session in transfusion medicine. Hematology (Am Soc Hematol Educ Program) 2003 : 575 89.
9. Brecher ME, Hay SN. Improving platelet safety: bacterial contamination of platelets. Curr Hematol Rep 2004 3 : 121 7.
10. Munksgaard L, Albjerg L, Lillevang ST, et al. Detection of bacterial contamination of platelet components: six years' experience with the BacT/ALERT system. Transfusion 2004 44 : 1166 73.
11. AuBuchon JP, Petz LD, Fink A, editors. Policy alternatives in transfusion medicine. Bethesda : American Association of Blood Banks 2001.
12. Devine P, Goldstein R, Linden JV, et al. Data on apheresis, blood collection, and transfusion-related activities: statistical analyses of the American Association of Blood Banks institutional membership questionnaires. Transfusion 1996 36 : 375 81.
13. Nydegger UE, Schneider P. Production of platelet concentrates in Switzerland. Transfus Sci 1997 18 : 19 20.
14. Murphy S, Heaton WA, Rebulla P. Platelet production in the Old World - and the New. Transfusion 1996 36 : 751 4.
15. Heaton WA, Rebulla P, Pappalettera M, Dzik WH. A comparative analysis of different methods for routine blood component preparation. Transfus Med Rev 1997 11 : 116 29.
16. van Delden CJ, de Wit HJ, Sibinga CT. Comparison of blood component preparation systems based on buffy coat removal: component specifications, efficiency, and process costs. Transfusion 1998 38 : 860 6.
17. Katz AJ, Carter CW, Saxton P, et al. Simulation analysis of platelet production and inventory management. Vox Sang 1983 44 : 31 6.
18. Critchfield GC, Connelly DP, Ziehwein MS, et al. Automatic prediction of platelet utilization by time series analysis in a large tertiary care hospital. Am J Clin Pathol 1985 84 : 627 31.
19. Amin M, Fergusson D, Wilson K, et al. The societal unit cost of allogenic red blood cells and red blood cell transfusion in Canada. Transfusion 2004 44 : 1479 86.
20. Murphy S. Platelets from pooled buffy coats: an update. Transfusion 2005 45 : 634 9.
21. Larsson S, Sandgren P, Sjodin A, et al. Automated preparation of platelet concentrates from pooled buffy coats: in vitro studies and experiences with the OrbiSac system. Transfusion 2005 45 : 743 51.
22. Sullivan MT, Wallace EL. Blood collection and transfusion in the United States in 1999. Transfusion 2005 45 : 141 8.
23. Snyder EL, Elfath MD, Taylor H, et al. Collection of two units of leukoreduced RBCs from a single donation with a portable multiple-component collection system. Transfusion 2003 43 : 1695 705.
24. Novis DA, Renner S, Friedberg RC, et al. Quality indicators of fresh frozen plasma and platelet utilization. Arch Pathol Lab Med 2002 126 : 527 32.
25. Gerdtham UG, Lothgren M, Tambour M, Rehnberg C. Internal markets and health care efficiency: a multiple-output stochastic frontier analysis. Health Econ 1999 8 : 151 64.
26. Ledman RE, Groh N. Platelet production planning to ensure availability while minimizing outdating. Transfusion 1984 24 : 532 3.
27. Hoffmeister KM, Josefsson EC, Isaac NA, et al. Glycosylation restores survival of chilled blood platelets. Science 2003 301 : 1531 4.
28. Blajchman MA, Goldman M, Baeza F. Improving the bacteriological safety of platelet transfusions. Transfus Med Rev 2004 18 : 11 24.
29. Lam HC, Kominski GF, Petz LD, Sofaer S. Factors affecting the labor efficiency of hospital-based blood bank laboratories. Transfusion 1994 34 : 811 7.
30. Pitocco C, Sexton TR. Alleviating blood shortages in a resource-constrained environment. Transfusion 2005 45 : 1118 26.